Answers are grounded in this paper and cite their sources.
Observational analysis reveals uromodulin supports metabolism in the urobiome via Bifidobacterium longum, suggesting new dynamics in urinary health.
Uromodulin (UMOD), the most abundant urinary glycoprotein, protects against urinary tract infections through glycan-mediated pathogen binding; nevertheless, its interactions with commensal bladder microbiota (urobiome) remain unexplored. Based on our previous bioinformatics analysis on the urobiome's capacity to digest host glycans with glycosyl hydrolase genes (GHs), we hypothesized that UMOD may serve as a nutrient source for selected bacteria. We cultured one of them, Bifidobacterium longum, in a minimal medium supplemented solely with purified UMOD. Our results indicate that UMOD is degraded by B. longum , supporting a new role for UMOD in the urobiome's metabolism.
No takes yet. Share an insight, caveat, or question.
Khoury et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: